SPRY1 and medullary thyroid gland carcinoma: In 2012, Macia et al. [139] reported that Spry1 is expressed in mouse thyroid C-cells and that targeted deletion of Spry1 causes C-cell hyperplasia, a precancerous lesion preceding medullary thyroid carcinoma (MTC), in young adult mice.